Development News Edition
Give Feedback

Ajanta Pharma posts 11.60 percent rise in net profit at Rs 105.79 crore in Q1

"We are pleased with our June quarter performance which is in line with our expectations. Branded generic business in India and Export markets posted healthy growths," MD Yogesh Agrawal said.


PTI 31 Jul 2018, 10:22 AM India

Ajanta Pharma today reported 11.60 percent rise in consolidated net profit at Rs 105.79 crore for the June quarter on account of robust sales in branded generic business.

The company had posted a net profit of Rs 94.79 crore in the year-ago period, Ajanta Pharma said in a BSE filing. Consolidated income from operations stood at Rs 510.99 crore for the reported quarter. It was Rs 473.12 crore for the same period a year ago.

"We are pleased with our June quarter performance which is in line with our expectations. Branded generic business in India and Export markets posted healthy growths," MD Yogesh Agrawal said.

Despite challenging pricing environment in the US, the company has posted healthy growth for the quarter, he added.

"Going forward, branded generic business in India and Emerging Markets, and generic business in the US will be key focus markets for us," Agrawal said.

Shares of Ajanta Pharma were today trading at Rs 1,140.35 per scrip on BSE, up 1.01 percent from the previous close.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


add banner

LEAVE COMMENT